A report published by Cancer Research UK has highlighted a "golden age" of progress in cancer diagnosis and treatment, with the proportion of people surviving cancer in the UK doubling since the 1970s. According to data on cancer mortality and cases spanning 50 years, half of those diagnosed will now survive for 10 years or more. This marks a significant increase from 24% previously.
Key Findings
- The rate of people dying from cancer has fallen by 23% since the 1970s.
- Some cancers have shown more pronounced declines:
- Breast cancer deaths have dropped by nearly two-thirds.
- Lung and liver cancers have decreased by around one-third.
Disparities in Survival Rates
Despite the overall improvements, women have not experienced as much progress as men since the seventies, even though they have higher overall survival rates. The report notes significant disparities between different types of cancer regarding survival rates.
Expert Insights
Michelle Mitchell, chief executive of Cancer Research UK, stated:
"We’re living through a golden age for progress against many types of cancers – but we mustn’t be complacent."
She emphasized the exciting breakthroughs with immunotherapy drugs that target specific genetic mutations driving tumor growth. However, she also pointed out that access to these advancements is limited due to their expense.
Challenges in Early Detection
Despite the gains, challenges persist in early detection and timely treatment:
- Only about half of patients are diagnosed at an early stage, although this number has improved slightly compared to before the COVID-19 pandemic lockdowns.
- In England, roughly 49% of patients were diagnosed at an early stage, a proportion that has remained relatively stable over nearly a decade despite sustained pressure on NHS services during the pandemic.
Areas for Further Research
The report highlights several areas where further research is needed, including:
- Optimizing the use of existing treatments such as:
- Chemotherapy
- Radiotherapy
- Hormone therapy
- Targeted therapy
- Immunotherapy
- Stem cell transplants
- Gene editing therapies
- CAR-T cell therapies
- Checkpoint inhibitors
- Bispecific antibodies
- Monoclonal antibodies
- PARP inhibitors
- PI3K inhibitors
- MEK inhibitors
- BRAF V600E inhibitors
- BTK inhibitors
- BCL-2 antagonists
- CDK4/6 inhibitors
- mTORC1/2 kinase inhibitors
- AKT pathway modulators
Overall, while there have been significant gains made in reducing mortality rates associated with certain types of cancer, continued efforts are necessary to address the disparities and challenges that remain.

I’m Mark W. Lamplugh Jr., a visionary Chief Executive Officer, Board Member, and best-selling Author with over 25 years of experience driving significant revenue growth and optimizing ROI across the healthcare, wellness, and media industries. Throughout my career, I’ve consistently transformed underperforming operations into thriving ventures by building top-tier marketing organizations, implementing data-driven strategies, and leading transformational change. My empathetic, collaborative, and adaptable leadership style has allowed me to cultivate inclusive cultures of innovation, develop and retain top talent, and forge strong partnerships that fuel organizational success.
Adept in executive leadership, strategic business planning, and brand and marketing strategy, I have a proven track record of boosting annual revenues—achieving up to $1.3B in oncology over three years and generating $360M in mental health initiatives. My approach combines strategic vision with hands-on execution, as evidenced by my success in launching innovative facilities, expanding services for addiction and mental health care, and enhancing organizational brand visibility. As author of “The AI Marketing Playbook,” I contribute thought leadership on the integration of artificial intelligence in marketing, a role that showcases my commitment to staying at the forefront of industry innovation.
I also bring my insights and expertise to a broad audience as the host of cable tv & global streaming of “Street Level Marketing Show,” while my writing has been featured in major publications such as Entrepreneur, Business.com, The Startup, and Kivo Daily. Whether I’m implementing targeted digital marketing campaigns that engage over a million individuals monthly or overseeing multi-million dollar budgets to maximize return on investment, I approach every challenge with a combination of strategic planning, creative problem-solving, and unwavering dedication. Above all, I am passionate about expanding access to high-quality addiction and mental health care through innovative solutions that drive both patient outcomes and organizational growth.
Mark serves on the board of One World for Life, National Fire Heritage Center, and the Institute for Responder Wellness.
Mark (https://marklamplugh.com) is one of the top marketing executives in the United States and has revolutionized how companies reach potential clients thru influence, SEO, social, PR, and traditional marketing. His expertise in Marketing, Social Media, Digital Marketing, and Public Relations has generated millions of dollars in revenue for several national companies. Mark documents many of his techniques in his book “Beginners Guide to Social & Digital Media.” and “Marketing Playbook for Social Media,” which was named the top 100 social media marketing books of all time by Book Authority. He’s also a professional advocate for the behavioral and mental health of firefighters and other first responders. Marks articles have been published in Better Marketing, Startup Magazine, Social Media Today, Kivo Daily, Biz Catalyst 360, Fire Engineering, Firehouse Magazine, and several others.
One of his companies, niches, are marketing products and services to the public safety industry and their employees, specifically mental & behavioral health services. He can be reached for comment at ceo@influencemediasolutions.com
23,000 #1 Connections, 40,000,000 US B2B Contacts and 300,000,000 B2b/B2C email contacts as well as 1,000,000+ monthly social media reach. https://marklamplugh.com





















